SMART Pharmaceutical Consulting is a boutique pharmaceutical and biotechnology consulting firm that provides progressive ...

Investment analysts at HC Wainwright dropped their Q2 2025 earnings estimates for Enanta Pharmaceuticals in a report released on Tuesday, February 11th. HC Wainwright analyst E. Arce now expects that ...

Recursion is advancing REC-617, a promising reversible, non-covalent CDK7 inhibitor, showing potential in treating advanced solid tumors with positive interim phase 1 data. Read more here.

HOUSTON - Moleculin Biotech, Inc. (NASDAQ:MBRX), a pharmaceutical company specializing in treatments for tumors and viruses, has initiated the exercise of existing warrants which is expected to ...

We recently published a list of 10 Best Mid-Cap Growth Stocks to Buy According to Analysts. In this article, we are going to ...

Encoded’s layoffs will mostly affect its technology and early-stage research and development functions. The move is expected ...

Discover seven companies operating in metabolomics, the field that could significantly boost precision medicine.

Isomorphic Labs, a spin-off from DeepMind, is applying AI-first principles to drug discovery rather than just protein ...

U.S. investors and large pharmaceutical companies are increasingly doing deals in China as the country’s biopharma sector ...